Insights into the impact of sodium-glucose cotransporter 2 inhibition on urinary tract malignancy: A two-sample Mendelian randomization.

Han, Zeyu; He, Yazhou; Li, Xue; Li, Sheyu; Ai, Jianzhong

Han, Zeyu; He, Yazhou; Li, Xue; Li, Sheyu; Ai, Jianzhong.

Afiliação

Han Z; Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, China.
He Y; Department of Oncology/Department of Epidemiology and Medical Statistics, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, China.
Li X; School of Public Health and the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Li S; Department of Endocrinology and Metabolism, Division of Guideline and Rapid Recommendation, Cochrane China Center, MAGIC China Center, Chinese Evidence-Based Medicine Center, West China Hospital, Sichuan University, Chengdu, China.
Ai J; Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, China.

Diabetes Obes Metab ; 26(5): 1986-1989, 2024 May.

Article em En | MEDLINE | ID: mdl-38356116

Assuntos

Análise da Randomização Mendeliana; Neoplasias Urológicas; Humanos; Hipoglicemiantes; Glucose; Sódio; Estudo de Associação Genômica Ampla

Palavras-chave

Mendelian randomization; bladder cancer; prostate cancer; renal cell carcinoma; sodiumglucose cotransporter 2

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Urológicas / Análise da Randomização Mendeliana Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google